The Europe Livestock Diagnostics Market is expected to record a CAGR of 7.2% from 2024 to 2031, reaching $788.2 million by 2031. European countries have a major focus on the production, consumption, and export of animal-derived food products. In order to ensure the best quality of food products derived from animals, superior animal health is essential. Diagnostics is crucial to keeping animals healthy by enabling early disease diagnosis and preventing disease spread amongst animals. Technologies such as immunodiagnostics and molecular diagnostics are used to diagnose diseases such as influenza, swine fever, foot & mouth disease, and blue tongue, among others.
The growth of this market is driven by the increasing livestock population, the increasing prevalence of food-borne and zoonotic diseases, and the presence of well-developed animal health infrastructure in the region. Additionally, favorable initiatives and policies to improve animal health and rising demand for animal-derived food products are expected to create growth opportunities for the stakeholders in this market. However, the shortage of veterinarians in rural areas of Europe poses a major challenge to the growth of this market.
Rising Demand for Animal-derived Food Products to Drive the Market
The demand for animal-derived food products, namely meat, milk, and eggs, has increased. The consumption of animal-derived foods is increasing due to decreasing agricultural productivity on account of shrinking resources and reduced availability of cultivable land. Foods derived from animals are a major source of protein, and a protein-rich diet is essential to leading a healthy life.
Consumption of animal proteins is stable (around 44 to 55 g/capita/day) in developed countries, while consumption is increasing in developing regions. Similarly, according to the OECD-FAO Agricultural Outlook in 2027, poultry consumption is expected to increase to 24.8kg per capita from 23.5kg per capita in 2021 in Europe. Farmers are expected to increase livestock populations to meet the increasing demand for animal-derived foods. Increased livestock production will encourage the adoption of diagnostic testing for animals. Diagnostic testing helps detect diseases early and starts a proper treatment to ensure the safety and quality of animal-derived food products by preventing the spread of diseases. This is one of the major factors driving the market growth.
![Europe Livestock Diagnostics Market Europe Livestock Diagnostics Market](https://www.meticulousresearch.com/public/website_images/Europe-Livestock-Diagnostics-Market.webp)
Click here to: Get Free Sample Pages of this Report
Increasing Prevalence of Foodborne and Zoonotic Diseases Drives the Market
Over the last century, there has been an alarming increase in the number, frequency, and diversity of zoonotic disease outbreaks. Caused by the spillover of pathogens from animal hosts to people, these events may have more than tripled in the last decade, with the number of new zoonotic diseases infecting people quadrupling over the same period globally.
Similarly, several cases of zoonotic diseases have been reported in the European region. For instance, according to the European Union One Health 2021 Zoonoses Report, 127,840 human cases of Campylobacteriosis, followed by 60,050 cases of Salmonellosis, and 6,789 cases of Yersiniosis were reported in 2021. To prevent infections from such zoonotic diseases rapid and early testing is essential also to curb the spread of infections, leading to the adoption of diagnostic tests in the region.
Key Findings of the Europe Livestock Diagnostics Market Study:
The Consumables Segment to Dominate the Europe livestock Diagnostics market in 2024
Being recurrent use, their demand increases with rising livestock diagnostic test volume, awareness regarding regular animal health check-ups, and increasing livestock population. Moreover, the emergence of various POC tests and assays is expected to create significant opportunities in the Europe livestock diagnostics market.
The Immunodiagnostics Segment to Account for the Largest Market Share in 2024
Immunodiagnostics is a preferred technology in diagnostics and quality-control programs, as they are rapid, convenient, and accurate research tools for detecting and quantifying targets. Further, the continuous development of new biomarkers & their cost-benefit and growing adoption of automated platforms for ELISA contribute to the large share of the segment.
The Ruminants Segment to Account for the Largest Market Share in 2024
The segment's large share is attributed to the high prevalence of diseases in ruminants, the large population base of ruminants in the region, and the constant health monitoring required for ruminants to ensure high productivity.
The Reference Laboratories Segment to Account for the Largest Market Share in 2024
The segment's large share is attributed to the higher adoption of livestock diagnostic products by reference laboratories, growing research activities in these labs leading to advancements in the existing procedures used for animal health diagnosis, and growing preference for clinics, small to mid-sized hospitals, and farm owners towards utilizing health screening and diseases diagnostic services offered by reference laboratories for complex tests.
Germany to Dominate the Market in 2024
In 2024, Germany is expected to dominate the Europe Livestock Diagnostics Market. The large share is attributed to the high demand and consumption of animal-derived food proteins, the presence of large exporters of animal products, the export of large volumes of animal-derived food products, and the high production of animal-derived products. For instance, according to data from the Federal Statistical Office (Destatis), in 2022, Germany exported almost 2.9 million tons of meat and meat products, mostly to other European Union (EU) countries.
Key Players
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in this market in the last three to four years. The key players profiled in the Europe Livestock Diagnostics Market are IDEXX Laboratories, Inc. (U.S.), Zoetis Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), INDICAL BIOSCIENCE GmbH (Germany), Agrolabo SpA (Italy), Neogen Corporation (U.S.), IDvet (France), BioChek B.V. (Hungary), MEGACOR Diagnostik GmbH (Austria), and GD Animal Health (Netherlands).
Report Summary:
Particular
|
Details
|
Number of Pages
|
~200
|
Format
|
PDF
|
Forecast Period
|
2024-2031
|
Base Year
|
2023
|
CAGR
|
7.2%
|
Estimated Market Size (Value)
|
$788.2 million by 2031
|
Segments Covered
|
By Product
- Consumables
- Bovine Viral Diarrhea
- Influenza
- Swine Fever
- Foot & Mouth Disease
- Bluetongue (BTV)
- Other diseases
(Note: Other diseases include Bovine herpes virus (BHV), Brucellosis, Porcine reproductive and respiratory syndrome (PRRS), and Avian Mycoplasma, among others)
- Systems
- Software
By Animal Type
- Ruminants
- Bovine Animals
- Other Ruminants
(Note: Other Ruminants include sheep, goats, deer, elk, giraffes, and camels)
- Poultry
- Swine
- Other Livestock
(Note:Other livestock include equine and fish)
By Technology
- Immunodiagnostics
- ELISA
- Other Immunodiagnostic Technologies
(Note: Other immunodiagnostic technologies include virus neutralization test, hemagglutination inhibition assay, and agar gel immunodiffusion test, among others)
- Molecular Diagnostics
- PCR
- Other Molecular Diagnostic Technologies
(Note: Other molecular diagnostic technologies primarily include microarrays, DNA sequencing, and next-generation sequencing, among others)
- Other Technologies
(Note: Other technologies primarily include microbiology, clinical biochemistry, hematology, urinalysis, and histopathology tests)
By End User
- Veterinary Hospitals & Clinics
- Reference Laboratories
- Point-of-care/At-farm Testing
|
Countries Covered
|
Europe (Germany, France, Italy, U.K., Spain, Denmark, Switzerland, Poland, Netherlands, Romania, Austria, Rest of Europe)
|
Key Companies
|
IDEXX Laboratories, Inc. (U.S.), Zoetis Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), INDICAL BIOSCIENCE GmbH (Germany), Agrolabo SpA (Italy), Neogen Corporation (U.S.), IDvet (France), BioChek B.V. (Hungary), MEGACOR Diagnostik GmbH (Austria), and GD Animal Health (Netherlands))
|
Key questions answered in the report: